[go: up one dir, main page]

TW201103897A - Purification method of mycophenolic acid and method for preparing high purity sodium mycophenolate using the same - Google Patents

Purification method of mycophenolic acid and method for preparing high purity sodium mycophenolate using the same Download PDF

Info

Publication number
TW201103897A
TW201103897A TW98124527A TW98124527A TW201103897A TW 201103897 A TW201103897 A TW 201103897A TW 98124527 A TW98124527 A TW 98124527A TW 98124527 A TW98124527 A TW 98124527A TW 201103897 A TW201103897 A TW 201103897A
Authority
TW
Taiwan
Prior art keywords
acid
mmol
mycophenolic acid
solution
mycophenolate
Prior art date
Application number
TW98124527A
Other languages
Chinese (zh)
Other versions
TWI382023B (en
Inventor
guang-zong Li
Bing-Shu Chen
Rui-Hua Qiu
An-Ping Li
Original Assignee
Chunghwa Chemical Synthesis & Biotech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chunghwa Chemical Synthesis & Biotech Co Ltd filed Critical Chunghwa Chemical Synthesis & Biotech Co Ltd
Priority to TW98124527A priority Critical patent/TW201103897A/en
Publication of TW201103897A publication Critical patent/TW201103897A/en
Application granted granted Critical
Publication of TWI382023B publication Critical patent/TWI382023B/zh

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

This invention relates to a purification method of mycophenolic acid and preparation of high purity sodium mycophenolate. The mycophenolic acid to be purified is converted into a mycophenolic acid ester derivative and through the differences in physical property between the mycophenolic acid and mycophenolic acid ester derivative, the impurities in the mycophenolic acid that was hard to remove is reduced. After the purified mycophenolic acid ester derivative undergoes hydrolysis reaction in a sodium hydroxide aqueous solution and is performed with steps of acidification, extraction, concentration and re-crystallization, the mycophenolic acid is obtained, wherein the content of the impurities is far below 0.10%. The sodium mycophenolate is the prodrug of mycophenolic acid, and in the preparation condition of the sodium mycophenolate, the purity of mycophenolic acid has crucial influences on the quality of the sodium mycophenolate product. The purified mycophenolic acid and sodium-containing organic alkaloid or inorganic alkaloid are performed with the saponification reaction the sodium mycophenolate is obtained, wherein the content of the impurities is far below 0.10%.

Description

201103897 六、發明說明: 【發明所屬之技術領域】 霉酚酸之化學結構如下式(丨)所示:201103897 VI. Description of the invention: [Technical field to which the invention belongs] The chemical structure of mycophenolic acid is as follows:

霉酶酸是一種免疫抑制劑(immunosuppressant ),用於器官移 植,避免器官接受者對新植入的器官產生排斥。霉酚酸係次黃嘌 呤核音單峨酸脱虱酶(inosine monophosphate dehydrogenase, IMPDH)抑制劑’可經由控制嗓呤(purine)的重新合成(也即v〇 synthesis)途徑’抑制淋巴τ細胞與B細胞的活化增生。此外, 霉酚酸也具有抗腫瘤(antitumor)、抗霉菌(amifimgal)、抗細菌 (antibacterial)以及抗病毒(antivirai)的特性(參閱專利us 2008/0293110 A1與文中所提列之參考文獻與專利)。 【先前技術】 在專利US 2008/0293110 A1中,發表霉紛酸的單離方法,係 利用適當的驗與發酵液(fermentation broth)混合,授拌、過濾後, 經由酸化、析晶、過遽後得到的霉驗酸,以甲苯再結純化後,純 度可達到99.2%。 3 201103897 在專利WO 2009/040828 A1中,發表霉酚酸的純化方法,係 先利用低體積莫耳濃度的碳酸鈉水溶液,萃取出霉酚酸之乙酸乙 酯溶液中的極性(polar)不純物;之後’再以氫氧化鈉水溶液, 對霉酚酸的乙酸乙酯溶液進行連續萃取;合併後的氫氧化鈉萃取 液,再以正丁醇萃取出霉酚酸之乙酸乙酯溶液中非極性 (non_polar)的不純物。萃取後的氫氧化鈉水溶液,經酸化、萃 取、有機溶劑再結,得到純化後的霉酚酸;在此篇專利的實施例 •(一)中,收率為60%,其中,霉酚酸中的不純物含量最高者為 0.12% ;於實施例(二)中,收率僅50%,其中,霉酚酸中有數個 不純物含量介於0.10〜0.12% ;於實施例(三)中,收率雖然可達 80% ’但是,霉酚酸中仍有數個不純物含量介於〇 1〇〜〇 13〇/〇。 雖然,依專利WO 2009/040828 A1中發表的純化方法,得到 的霉盼酸,其純度高於專利US 2008/0293110 A1中發表的方法, 但是’其中所含有之個別不純物含量仍然高於〇 1〇%之邊界範圍之 修上’根據1CH指引(ICH guidelines),凡個別不純物大於〇.1〇〇/0以 上,須將其單離出並進行結構鑑定,因此,此法仍非理想的純化 方法。 【發明内容】 按霉酚酸(1) ’係經由發酵製程所產生之化合物,利用一般有 機溶劑再結的方法,無法有效降低伴隨著霉酚酸〇)所產生的不 純物(位於RRT 〇.83, 3.65, 5.73, 5 87, 6 〇3 )。然而,在霉紛酸⑴ 4 201103897 的前體藥物霉紛酸鈉鹽⑴的製傷條件中,霉紛酸⑴的純度 對霉紛酸鈉鹽的品質則具有絕對的影響。 ,本發明係將霉_轉變為霉__衍生物,霉紛酸賴 街生物與_酸之間物性上的差異,_霉雜中不易去除的不 純物。所得到的霉__員衍生物,在驗金屬氫氧化物(a脑 hydroxide)水;谷液中進行水解反應,經酸化、萃取、濃縮、再結 等步驟’得到霉酴酸,其巾,不純物的含量皆遠低於〇1〇%以下, •收率 86.5%。 純化後的霉酚酸與含鈉的有機鹼或無機鹼進行皂化反應後, 可得到高純度的霉紛酸鈉鹽’其中,不純物的含量皆遠低於〇]〇% 以下。 本發明係利用酯化(esterification)反應,將欲純化之霉酚酸 (1)轉變為霉酚酸酯類衍生物(3),如流程丨所示,利用霉酚酸 (1)與霉酚酸酯類衍生物(3)之間物性上的差異,降低原本在 •霉酚酸(1)中不易移除的不純物。純化後的霉酚酸酯類衍生物 (3) ’於鹼金屬氫氧化物水溶液中進行水解反應後,經由酸化、 萃取、濃縮、再結等步驟,得到霉酚酸(1),其中,不純物(位 於 RRT 0.83, 3.65, 5.73, 5.87, 6.03 )含量皆遠低於 〇.10%以下。 5 201103897Mycophenolic acid is an immunosuppressant used for organ transplantation to prevent organ recipients from rejecting newly implanted organs. The mycophenolic acid hypoxanthine monophosphate dehydrogenase (IMDH) inhibitor can inhibit lymphatic tau cells by controlling the purine re-synthesis (ie, v〇synthesis) pathway. Activated proliferation of B cells. In addition, mycophenolic acid also has antitumor, amifimal, antibacterial, and antivirai properties (see patent US 2008/0293110 A1 and references and patents cited herein) ). [Prior Art] In the patent US 2008/0293110 A1, a method for the separation of moldy acid is disclosed, which is mixed with a fermentation broth by an appropriate test, and after being mixed and filtered, it is acidified, crystallized, and passed through. After the obtained acid test, after purification by toluene, the purity can reach 99.2%. 3 201103897 In the patent WO 2009/040828 A1, a method for purifying mycophenolic acid is disclosed, which first extracts a polar impurity in a solution of mycophenolic acid in an ethyl acetate solution using a low volume molar aqueous solution of sodium carbonate; After that, the extract of mycophenolic acid in ethyl acetate was continuously extracted with an aqueous solution of sodium hydroxide; the combined sodium hydroxide extract was extracted with n-butanol to extract non-polarity in the ethyl acetate solution of mycophenolic acid ( Non_polar) of impurities. The extracted aqueous sodium hydroxide solution is acidified, extracted, and re-agglomerated in an organic solvent to obtain purified mycophenolic acid; in the example (1) of this patent, the yield is 60%, wherein mycophenolic acid The highest impurity content is 0.12%; in the embodiment (2), the yield is only 50%, wherein the amount of impurities in the mycophenolic acid is between 0.10 and 0.12%; in the embodiment (3), Although the rate can reach 80% 'but, there are still several impurities in the mycophenolic acid content between 〇1〇~〇13〇/〇. Although, according to the purification method disclosed in the patent WO 2009/040828 A1, the obtained mycophenolic acid has a purity higher than that published in the patent US 2008/0293110 A1, but 'the content of the individual impurities contained therein is still higher than 〇1. 〇% of the boundary range of the repair "according to the 1CH guidelines (ICH guidelines), where the individual impurities are greater than 〇.1〇〇 / 0 or more, they must be separated and structurally identified, therefore, this method is still not ideal purification method. SUMMARY OF THE INVENTION According to the mycophenolic acid (1) 'system through the fermentation process, using the general organic solvent re-cure method, can not effectively reduce the impurities produced by the mycophenolate mofetil (located in RRT 〇.83 , 3.65, 5.73, 5 87, 6 〇 3 ). However, in the wounding conditions of the prodrug sodium salt (1) of mycophenolic acid (1) 4 201103897, the purity of the acid (1) has an absolute influence on the quality of the sodium salt. In the present invention, the mold is converted into a mildew-_derivative, and the difference in physical properties between the sulphate acid and the _acid is _yield which is difficult to remove in the mold. The obtained mildew derivative is subjected to a hydrolysis reaction in a water of a metal hydroxide (a brain hydroxide); a step of acidification, extraction, concentration, re-knotification, etc. to obtain a mycophenolic acid, a towel thereof, The content of impurities is much lower than 〇1〇%, and the yield is 86.5%. After the purified mycophenolic acid is saponified with a sodium-containing organic or inorganic base, a high-purity sodium sulphate salt can be obtained, wherein the content of the impurities is much lower than 〇] 〇 % or less. The present invention utilizes an esterification reaction to convert the mycophenolic acid (1) to be purified into a mycophenolate derivative (3), as shown in the scheme, using mycophenolic acid (1) and mycophenolic acid. The difference in physical properties between the acid ester derivatives (3) reduces the impurities which are not easily removed in the mycophenolic acid (1). After the purified mycophenolate ester derivative (3) 'hydrolyzed in an aqueous alkali metal hydroxide solution, the mycophenolic acid (1) is obtained by acidification, extraction, concentration, re-cylinder, etc., wherein the impurity (Located at RRT 0.83, 3.65, 5.73, 5.87, 6.03) are well below 〇.10%. 5 201103897

流程1Process 1

3b: R=CH2〇H3 3c: R=CH2CH2CH3 3d: R=CH(CH3)23b: R=CH2〇H3 3c: R=CH2CH2CH3 3d: R=CH(CH3)2

3e: R=CH,CH,-|^〇3e: R=CH, CH, -|^〇

Hydrolysis | HydrolysisHydrolysis | Hydrolysis

本發明之霉酚酸(1 )純化製程包含下述反應與過程之組合(戋 步驟): (1)醋化反應 將醇類(alcohol) (4)與霉酚酸(1),在有機酸對—曱笨磺 酸(Wra-toluenesulfonic acid,簡稱p-TSA) (5)的催化下,進行 鲁酯化反應’產生霉齡酸烧酯(alkyl mycophenolate) (3a-d),霉紛 酸烷酯(3a-d)可在醇類(4)溶液中析出而得。 此外,所得到的霉盼酸酯類衍生物(3)亦可於醇類(4)中 進行再結純化;於醇類(4)中再結純化後的霉酚酸酯類衍生物 (3),可以更有效地提高水解後所產生之霉酚酸的純度。 本發明即是將欲純化之霉酚酸(1),轉變為霉酚酸酯類衍生 物(3),利用霉酚酸(D與霉酚酸酯類衍生物(3)之間物性上 的差異’降低原本在霉紛酸(1)中不易移除的不純物。然而,有 6 201103897 些醇類分子太大,如2· (4-嗎琳)乙醇(2_(4_m()rph()linyl)ethan()1) (6)’無法直接與霉酚酸(1)進行酯化反應,因此,將霉酚酸〇) 轉變為霉驗酸烧S旨(3a-d )後,再與其進行醋交換 (transesterification)反應,以得到所欲之酯類衍生物,反應如流 程1所示。 將2- (4-嗎琳)乙醇(6)與霉酚酸烷酯(3a_d)在二丁基錫 氧化物(dibutyltinoxide)的催化下,於曱苯中進行酯交換反應, • 產生霉酚酸2_ (4_嗎啉)乙酯(3e)。 所產生之霉紛酸2- (4·嗎琳)乙醋(3e),酸化後溶於水層, 經有機溶劑,如乙酸乙酷’萃取後,可以有效移去原本霉盼酸中 (1)不易去除之不純物。經由驗化、有機溶劑萃取、濃縮、乾燥 後之霉酴酸2- (4-嗎淋)乙醋(3e),於水解後可得到高純度的霉 盼酸。 _ (2)霉酚酸酯類衍生物(3)的水解反應 霉酚酸酯類衍生物(3)於鹼金屬氫氧化物水溶液中進行水解 反應後,再經由酸化、萃取、漠縮、再結等步驟,得到霉齡酸⑴, 其中’不純物的含量皆遠低於0.10〇/〇以下。 霉酚酸酯類衍生物(3)的水解過程中,鹼金屬氫氧化物的當 量數可由LOW當量’以3.〇〜Μ當量最適合。驗金屬氣氧化物 可為氫氧化鐘、氫氧化納以及氫氧化鉀,其中以氣氧化納最適合。 反應時間可由2〜36小時,以4〜24小時_合。反應溶液酸化後 7 201103897 的pH值可由0.3〜3.5,以0.5〜2·0最適合。 本發明即是利用霉紛酸(1)與霉酴酸醋類衍生物(3)之間 物性上的差異’來降低霉齡酸中不易移除的不純物,以得到品質 高、不純物含量低的霉酚酸(1)。 霉酚酸酯類衍生物(3)在醇類(4)中再結純化後,可以使 水解後產生的霉酚酸(1) ’純度更有效地提高之外,霉酚酸烷酯 鲁 (3a-d)與2_ (4-嗎啉)乙醇(6) ’在進行酯交換反應後,所產生 的霉酚酸2-(4-嗎啉)乙酯(3e)’於水解後可得到高純度的霉酚 酸(1) ’其中,不純物含量皆低於0.05%。 除了發酵製程所伴隨而生的不純物之外,霉紛酸(^)在經石夕 藻土(celite)過濾的純化過程中,常會出現一般有機溶劑再結不 易去除的深紫色。本發明係利用對—甲苯磺酸(5),將其與霉酚 酸(1)的再結溶液混合,析晶、過濾後,即可得到白色之霉酚酸 # (1)固體。 於霉酚酸(1)的有機溶劑再結過程中,對—甲苯磺酸(5) 的使用量可為G.GG1〜G.2G當量,其中,以_2〜q 15當量最適合。 在霉盼酸⑴的前體藥物霉紛酸鈉鹽⑴的製備條件中, 霉酴酸⑴的純度對霉紛酸納鹽⑴的品質具有決定性的影響。 將純化後的_酸⑴與含_有機驗或無鑛進行4化反應, 得到的霉酴酸納鹽(2),其中,不純物的含量皆遠低於〇1〇%以下。 8 201103897 【實施方式】 本發明可由以下諸實施例說明其製程,但本發明之範圍並非侷 限在以下所述之實施例。 於下列各實施例中所述及之反應,皆利用高效能液相層析儀 (HPLC,Waters)對反應起始物、中間體以及產物進行分析,高效 能液相層析儀之分析條件如下:The mycophenolic acid (1) purification process of the present invention comprises the following combination of reaction and process (戋 step): (1) vineification reaction of alcohol (alcohol) (4) with mycophenolic acid (1) in organic acid Under the catalysis of Wra-toluenesulfonic acid (p-TSA) (5), the esterification reaction produces 'alkyl mycophenolate (3a-d), mycophenolate The ester (3a-d) can be obtained by precipitation in an alcohol (4) solution. Further, the obtained mycophenolate derivative (3) can also be re-purified in the alcohol (4); and the mycophenolate derivative after re-purification in the alcohol (4) (3) ), the purity of mycophenolic acid produced after hydrolysis can be more effectively improved. The invention converts the mycophenolic acid (1) to be purified into the mycophenolate ester derivative (3), and utilizes the physical property between the mycophenolic acid (D and the mycophenolate ester derivative (3). The difference 'reduced the impurities that were not easily removed in the soy acid (1). However, there are 6 201103897 some alcohol molecules are too large, such as 2 · (4- morphine) ethanol (2_(4_m()rph()linyl) )ethan()1) (6) 'The esterification reaction cannot be directly carried out with mycophenolic acid (1). Therefore, after changing the mycophenolate mofetil) to the mold test acid (S), (3a-d), The transesterification reaction is carried out to obtain the desired ester derivative, and the reaction is shown in Scheme 1. 2-(4-Merlin) ethanol (6) and mycophenolate (3a_d) are transesterified in terpene benzene under the catalysis of dibutyltinoxide. • Produce mycophenolic acid 2_ ( 4_morpholine)ethyl ester (3e). The resulting mildew acid 2-(4·Merlin) ethyl vinegar (3e) is dissolved in the water layer after acidification, and can be effectively removed by extraction with an organic solvent such as ethyl acetate (1) ) Impure that is not easy to remove. After the hydrolysis, the organic solvent extraction, concentration, and drying of the mycophenolic acid 2-(4-loryl)acetic acid (3e), high-purity mycophenolic acid can be obtained after hydrolysis. _ (2) hydrolysis reaction of mycophenolate derivatives (3) Mycophenolate derivatives (3) are hydrolyzed in an aqueous alkali metal hydroxide solution, followed by acidification, extraction, condensation, and further In the step of knotting, a mycophenolic acid (1) is obtained, wherein the content of the 'impurity is far below 0.10 〇 / 〇. In the hydrolysis of the mycophenolate derivative (3), the amount of the alkali metal hydroxide can be most suitably determined by the LOW equivalent of 3. 〇 to Μ. The metal oxide can be a hydroxide, sodium hydroxide or potassium hydroxide, of which sodium is most suitable for gas oxidation. The reaction time can be from 2 to 36 hours to 4 to 24 hours. After the acidification of the reaction solution, the pH of 7201103897 can be 0.3~3.5, and 0.5~2·0 is most suitable. The invention utilizes the difference in physical properties between the mycophenolic acid (1) and the mycophenolic acid vinegar derivative (3) to reduce the impurities which are not easily removed in the moldy acid, so as to obtain high quality and low impurity content. Mycophenolic acid (1). The refining of the mycophenolate ester derivative (3) in the alcohol (4) can further improve the purity of the mycophenolic acid (1)' produced after the hydrolysis, and the mycophenolate molybdenum ( 3a-d) and 2_(4-morpholine)ethanol (6)' After the transesterification reaction, the resulting mycophenolic acid 2-(4-morpholine)ethyl ester (3e)' can be obtained after hydrolysis. The purity of mycophenolic acid (1) 'where the impurities are less than 0.05%. In addition to the impurities produced by the fermentation process, the mild acid (^) in the purification process filtered through celite often has a deep purple color which is not easily removed by general organic solvents. In the present invention, p-toluenesulfonic acid (5) is used, and it is mixed with a re-synthesis solution of mycophenolic acid (1), and after crystallization and filtration, a white fungus phenolic acid # (1) solid can be obtained. In the re-junction process of the organic solvent of mycophenolic acid (1), the amount of p-toluenesulfonic acid (5) used may be G.GG1 to G.2G equivalent, and the most suitable one is _2 to q15 equivalent. In the preparation conditions of the prodrug sodium salt (1) of the mycophenolic acid (1), the purity of the mycophenolic acid (1) has a decisive influence on the quality of the solubilized sodium salt (1). The purified oxalic acid (1) is reacted with the organic-containing or non-mineralized 4-carbonated sodium salt (2), wherein the content of the impurities is much lower than 〇1〇%. 8 201103897 [Embodiment] The present invention can be illustrated by the following embodiments, but the scope of the present invention is not limited to the embodiments described below. In the reactions described in the following examples, the reaction starting materials, intermediates and products were analyzed by high performance liquid chromatography (HPLC, Waters). The analytical conditions of the high performance liquid chromatography were as follows. :

1·管柱(Column). ZORBAX,150 X 4.6 mm,Agilent C8 2·管柱溫度:45°C 3. 流動相(Mobile phase):混合 350 毫升乙腈(acet〇nitrile)、650 毫升純水以及2.0毫升三乙胺(triethylamine),以85%構酸水 溶液調混合溶液之pH值至5.3,震盪後使用。 4. 流速(Flowrate) : 0.8 mL/min. 5·偵測波長:250nm1. Column (Column). ZORBAX, 150 X 4.6 mm, Agilent C8 2. Column temperature: 45 ° C 3. Mobile phase: Mix 350 ml of acetonitrile (nit〇nitrile), 650 ml of pure water and 2.0 ml of triethylamine, the pH of the mixed solution was adjusted to 5.3 with 85% aqueous acid solution, and used after shaking. 4. Flowrate: 0.8 mL/min. 5. Detection wavelength: 250 nm

6.注射體積:10 uL 於此條件下’經由液相層析儀進行分析所顯示出之不純物, 其吸收峰的相對滯留時間(relative retention times,RRT)之誤差範 圍在-0.05至+0.05之間。 實施例1 (0 合成霉酚酸甲酯(MethylMycophenolate) 於反應瓶中加入霉酴酸(9.5克,29.7毫莫耳,其中,不純物 位於 RRT 0.83, 3.65, 6.03 的含量分別為 〇_16%,0.54%,0.54%)與 9 201103897 甲醇(250毫升),室溫下授拌反應混合物至澄清溶液,加入對— 甲苯猶(0.42克,2.4毫莫耳)。加熱反應溶液至迴流,攪拌2 小時。㊉壓蒸餾出甲醇(15〇毫升),降溫析晶,液溫達25。〇時以 冰水浴冷卻,並於液溫為時過濾,瓶壁與溼固體以冰甲醇洗, 屋固體於60 C乾燥’得到白色固體產物(9·4克,28.0毫莫耳), 產率94.4%。 (2)霉酚酸甲酯的水解 室溫下,於反應瓶中加入氫氧化納(3 8克,95 〇毫莫耳)與 純水(笔升)’授拌混合物至澄清水溶液。加入霉紛酸曱酯(9.0 克27.0毫莫耳),至溫下授拌21小時。反應溶液以乙酸乙酯(1〇〇 毫升)萃取,丟棄有機層。水層以32%鹽酸水溶液調ρΗ值至丨5, 以乙酸乙r目⑽毫升)萃取兩次。合併乙酸乙醋溶液,常壓下蒸 鶴出乙酸乙S旨(Π0毫升)’降溫析晶,液溫達坑時以冰水浴冷 卻’並於液溫rc時過滤’瓶壁與座固體以冰乙酸乙醋洗,渔固體 於60C乾燥,得到白色固體產物(7 9克,24 7毫莫耳,其中,不 純物位於RRT 0.83, 3·65, 6.G3的含量分別為G.G5%,〇.〇3%, 0.02%),產率 91.6% 〇 實施例2 (1)合成霉酚酸甲酯 於反應瓶中加入霉酚酸(3〇.〇克,93 8毫莫耳,其中,不純 物位於 RRT O.83, 3.65, π 的含量分別為 〇 2〇%,〇 s6%,〇 42%) 201103897 與甲醇(150毫升)’室溫下攪拌反應混合物至澄清溶液,加入對 —曱笨續酸(1.26克’ 7.3毫莫耳)。加熱反應溶液至迴流,擾拌2 小時。降溫析晶,室溫下以冰水浴冷卻,並於液溫為2。〇時過濾, 瓶壁與溼固體以冰曱醇洗,溼固體於60°C乾燥,得到白色固體產 物(28.8克,86.2毫莫耳),產率95.2%。 (2)合成霉驗酸2- (4-嗎琳)乙醋 於反應瓶中加入霉酚酸甲酯(2〇.〇克,59.9毫莫耳)、甲苯(74 4 •克)、2-(4-嗎琳)乙醇(8.3克’63.1毫莫耳)與2-丁基錫氧化物 (1.5克,6_0毫莫耳),加熱反應混合物至迴流,攪拌丨小時。降 溫,於反應溶液内溫46。(:時,加入2-丁基錫氧化物(6.0克,24.0 毫莫耳)’加熱反應混合物至迴流,於迴流溫度下,攪拌4〇小時。 降溫,於反應;谷液内溫48°C時,加入活性碳(1.〇克),授拌j小 時。加入乙酸乙酯(22.9克),攪拌5分鐘後,經矽藻土(ceUte) 過遽,瓶壁以乙酸乙醋(22.9克)洗,收集、合併遽液與洗液, 釀以純水(45.8克)洗。將有機溶液與純水(45 8克)混合、鮮, 以32%鹽酸水溶液調pH值至162,靜置分層,丢棄有機層,水層 以乙酸乙酯(45.8克)洗兩次。將水層與二氣甲烧(61 4克)混 合、攪拌’再以45%氫氧化鈉水溶液調pH值至1〇 83,靜置分層’ 收集有機層,水層以二氣甲烧(61.4克)萃取,合併有機層,以 飽和破躺水麵洗。將錢層濃縮至乾,固體雜物於6〇。〇 乾燥後’得到固體產物⑵.5克,49 6毫莫耳),產率82 8〇/〇。 (3)霉酌·酸2- (4-嗎琳)乙g旨的水解 201103897 室溫下’於反應瓶令加入氫氧化鈉(3 2克,78 8毫莫耳)與 純水(100 ί升),擾拌混合物至澄清水溶液。加入霉齡酸2· (4、_ 嗎琳)乙醋(10.0克,23.1毫莫耳),室溫下授拌4小時。反應溶 液以乙酸乙醋⑼毫升)萃取兩次,丟棄有機層,將水層與乙酸 乙酯(100毫升)混合並攪拌’以32〇/〇鹽酸水溶液調阳值至136, 靜置分層,收集有機層,水層以乙酸乙g旨(50亳升)萃取。合併 乙酸乙酯溶液,常壓下蒸餾出乙酸乙酯(140毫升),降溫析晶, #液溫達25〇C時以冰水浴冷卻’並於液溫為2。〇時過據,瓶壁與渥 固體以冰乙酸乙醋洗,澄固體於6(rc麟,得到白色固體產物(69 克,21.6毫莫耳,其中,不純物位於RRT 〇 83, 3 65, 5 73的含量 分別為 0.03%,<0.01%,0.01%),產率 93.5%。 實施例3霉酚酸除色 將紫色的霉酚酸(30.0克,93.8毫莫耳)與丙酮(150毫升) φ 於反應瓶中混合、攪拌,加入對一曱苯續酸(0.62克,3.6毫莫耳)。 加熱混合物至迴流(紫色消失,溶液呈淡黃色)。降溫析晶,室溫 下以冰水浴冷卻,並於液溫為2。(:時過濾,瓶壁與溼固體以冰丙_ 洗,溼固體於60°C乾燥,得到白色霉酚酸(24克,75毫莫耳), 產率80%。 實施例4霉酚酸鈉鹽的製備 於反應瓶中加入霉酚酸(5克,15.63毫莫耳,其中,不純物 12 201103897 位於RRT 0.83, 3.65的含量分別為〇.〇5%,〇,〇ι%)、氫氧化鈉(0 625 克’ 15.63毫莫耳)以及曱醇(1〇〇毫升),加熱反應混合物至迴流, 搜拌0.5小時後,蒸餾出曱醇(70毫升)。降溫,於液溫為26。〇時 加入異丙醇(70毫升)’加熱混合物至迴流,並蒸餾出甲醇/異丙 醇混合液(70毫升)。降溫,於液溫為24°C時過濾,瓶壁與溼固 體以異丙醇洗,溼固體於60°C乾燥,得到固體產物霉酚酸鈉鹽 (5.12克,14.97亳莫耳,其中,不純物位於狀丁仏幻,3 65的含 Φ 量分別為 0.04%, <0.01%),產率 95.8%。 iSMl霉酚酸鈉鹽的製備(比較製程) 於反應瓶中加入霉酚酸(5克,15.63毫莫耳,其中,不純物 位於 RRT 0.83, 3.65, 5.87 的含量分別為 〇.ΐ7〇/ό,〇.56%, 0.48%)、氫 氧化鈉(0.625克,15.63毫莫耳)以及曱醇(100毫升),加熱反 應混合物至迴流,攪拌0.5小時後’蒸餾出甲醇(7〇毫升)。降溫, ® 於液溫為28°C時加入異丙醇(70毫升),加熱混合物至迴流,並 蒸餾出曱醇/異丙醇混合液(70毫升)。降溫,於液溫為25。〇時過 濾,瓶壁與溼固體以異丙醇洗,溼固體於60艽乾燥,得到固體產 物霉酚酸鈉鹽(4.8克’ 14.04毫莫耳,其中,不純物位於rrto 83, 3.65, 5.87 的含量分別為 0.13%,0.04%,0.04%),產率 89.8%。 本發明製得之霉盼酸或霉盼酸納鹽其不純物含量可低至 0.05%或低於0.05%以下’遠優於前述先前技術(pri〇r _)之不純物 201103897 高於0.10%以上者。 【圖式簡單說明】 無 【主要元件符號說明】 無6. Injection volume: 10 uL Under these conditions, the impurities displayed by the liquid chromatograph showed a relative retention time (RRT) with an error range of -0.05 to +0.05. between. Example 1 (0 Methyl Mycophenolate) Methyl Mycophenolate was added to the reaction flask (9.5 g, 29.7 mmol), wherein the impurities were at RRT 0.83, 3.65, 6.03, respectively, 〇_16%. 0.54%, 0.54%) and 9 201103897 methanol (250 ml), the reaction mixture was stirred at room temperature to a clear solution, and p-toluene (0.42 g, 2.4 mmol) was added. The reaction solution was heated to reflux and stirred for 2 hours. Distilled methanol (15 〇ml) under ten pressures, cooled and crystallized, the liquid temperature reached 25. When it was cooled, it was cooled in an ice water bath, and filtered at the liquid temperature. The bottle wall and the wet solid were washed with ice methanol, and the solid was 60. C dried to give a white solid product (9·4 g, 28.0 mmol), yield 94.4%. (2) Hydrolysis of methyl mycophenolate. Add sodium hydroxide (3 8 g) to the reaction flask at room temperature. , 95 〇 millimolar) and pure water (pen liter) 'mix the mixture to a clear aqueous solution. Add the mycophenolate ester (9.0 g 27.0 mmol), and mix for 21 hours at the temperature. The reaction solution is acetic acid B. The ester (1 ml) was extracted and the organic layer was discarded. The aqueous layer was adjusted with 32% aqueous hydrochloric acid. The value was reduced to 丨5 and extracted twice with ethyl acetate (10 ml). Combined with ethyl acetate vinegar solution, steaming cranes under normal pressure to produce acetic acid B. ((0 ml) 'cooling and crystallization, when the liquid temperature reaches the pit, cool with ice water bath' and filter at the liquid temperature rc 'bottle wall and seat solids to ice The acetic acid was washed with acetic acid and dried at 60 C to obtain a white solid product (79 g, 24 7 mmol), wherein the impurities were located at RRT 0.83, 3·65, 6. G3 were respectively G.G5%, 〇 〇3%, 0.02%), yield 91.6% 〇Example 2 (1) Synthetic methyl mycophenolate was added to the reaction flask with mycophenolic acid (3 〇. gram, 93 8 mmol, of which impurities Located at RRT O.83, 3.65, π content is 〇2〇%, 〇s6%, 〇42%) 201103897 with methanol (150 ml) 'The reaction mixture is stirred at room temperature to a clear solution, and added to the 曱 曱 曱Acid (1.26 g '7.3 mmol). The reaction solution was heated to reflux and spoiled for 2 hours. The crystal was cooled and cooled, and cooled in an ice water bath at room temperature, and the liquid temperature was 2. After filtration, the wall and wet solid were washed with ice-cold alcohol, and the wet solid was dried at 60 ° C to give a white solid product (28.8 g, 86.2 mmol), yield 95.2%. (2) Synthetic mold acid 2- (4-Merlin) ethyl vinegar was added to the reaction flask with methyl mycophenolate (2 〇. gram, 59.9 mmol), toluene (74 4 • gram), 2- (4-Merlin) Ethanol (8.3 g '63.1 mmol) and 2-butyltin oxide (1.5 g, 6_0 mmol), the reaction mixture was heated to reflux and stirred for hr. The temperature was lowered and the temperature was 46 in the reaction solution. (:, adding 2-butyltin oxide (6.0 g, 24.0 mmol)), heating the reaction mixture to reflux, stirring at reflux temperature for 4 hrs. Cooling, reaction; when the internal temperature of the solution is 48 ° C, Add activated carbon (1. g), and mix for j hours. Add ethyl acetate (22.9 g), stir for 5 minutes, then pass through celite (ceUte), and wash the bottle wall with ethyl acetate (22.9 g) Collect and combine the mash and the washing liquid, and wash it with pure water (45.8 g). Mix the organic solution with pure water (45 8 g), fresh, adjust the pH to 162 with 32% hydrochloric acid aqueous solution, and let stand. The organic layer was discarded, and the aqueous layer was washed twice with ethyl acetate (45.8 g). The aqueous layer was mixed with the second gas (6 4 g), stirred, and then adjusted to pH 1 with 45% aqueous sodium hydroxide. 〇83, static layering' The organic layer was collected, and the water layer was extracted with two gas (61.4 g), and the organic layer was combined and washed with saturated water. The layer was concentrated to dryness, and the solid matter was 6 〇. After drying, 'solid product (2). 5 g, 49 6 mmol) was obtained, yield 82 8 〇 / 〇. (3) Molybdenum acid 2- (4-Merlin) B hydrolysis of 201103897 At room temperature 'In the reaction bottle, add sodium hydroxide (32 g, 78 8 mmol) and pure water (100 ί l), disturb the mixture to a clear aqueous solution. Methyl vinegar 2 (4, _ _ _ _) vinegar (10.0 g, 23.1 mmol) was added and the mixture was stirred at room temperature for 4 hours. The reaction solution was extracted twice with ethyl acetate (9 ml), and then the organic layer was evaporated, and the aqueous layer was mixed with ethyl acetate (100 ml) and stirred to adjust the pH value to 136 with a 32 〇/〇 aqueous hydrochloric acid solution, and allowed to stand for stratification. The organic layer was collected, and the aqueous layer was extracted with ethyl acetate (50 liters). The ethyl acetate solution was combined, and ethyl acetate (140 ml) was distilled off under normal pressure, and the crystals were cooled and crystallized. When the liquid temperature reached 25 ° C, it was cooled in an ice water bath and the liquid temperature was 2. When the time was over, the bottle wall and the sputum solid were washed with glacial acetic acid acetonitrile, and the solid was solidified at 6 (rc lin) to give a white solid product (69 g, 21.6 mmol), wherein the impurities were located at RRT 〇83, 3 65, 5 The content of 73 was 0.03%, <0.01%, 0.01%, respectively, and the yield was 93.5%. Example 3 Mycophenolic Acid Decolorization Purple Mycophenolic Acid (30.0 g, 93.8 mmol) and acetone (150 ml) φ Mix and stir in the reaction flask, add p-benzoic acid (0.62 g, 3.6 mmol). Heat the mixture to reflux (purple disappears, the solution is pale yellow). Decrease the crystal, ice at room temperature The water bath is cooled and the liquid temperature is 2. (: Filtered, the wall of the bottle and the wet solid are washed with ice, and the wet solid is dried at 60 ° C to obtain white mycophenolic acid (24 g, 75 mmol). The rate was 80%.Example 4 Preparation of mycophenolate sodium salt Mycophenolic acid (5 g, 15.63 mmol) was added to the reaction flask, wherein the impurity 12 201103897 was located at RRT 0.83, 3.65, respectively, 〇.〇5% , 〇, 〇ι%), sodium hydroxide (0 625 g ' 15.63 mmol) and decyl alcohol (1 〇〇 ml), heating the reaction mixture to After stirring for 0.5 hour, decyl alcohol (70 ml) was distilled off, and the temperature was lowered at a liquid temperature of 26. At the time of hydrazine, isopropanol (70 ml) was added to heat the mixture to reflux, and methanol/isopropanol was distilled off. Liquid (70 ml), cooled, filtered at a liquid temperature of 24 ° C, the wall of the bottle and the wet solid were washed with isopropyl alcohol, and the wet solid was dried at 60 ° C to obtain a solid product, mycophenolate sodium salt (5.12 g, 14.97).亳莫耳, in which the impurity is located in the shape of Ding, the Φ content of 3 65 is 0.04%, <0.01%), the yield is 95.8%. Preparation of iSMl mycophenolate sodium salt (comparative process) in the reaction bottle Mycophenolic acid (5 g, 15.63 mmol) was added, wherein the impurities were located at RRT 0.83, 3.65, 5.87, respectively, 〇.ΐ7〇/ό, 〇.56%, 0.48%), sodium hydroxide (0.625 g) , 15.63 millimolar) and decyl alcohol (100 ml), the reaction mixture was heated to reflux, stirred for 0.5 hours, then 'distilled methanol (7 mL). Cooling, ® was added isopropanol at a liquid temperature of 28 ° C ( 70 ml), heat the mixture to reflux, and distill off the decyl alcohol/isopropanol mixture (70 ml). The temperature was 25. When filtering, the bottle wall and the wet solid were washed with isopropyl alcohol, and the wet solid was dried at 60 Torr to obtain a solid product, mycophenolate sodium salt (4.8 g ' 14.04 mmol, wherein the impurity was located at rrto 83, The content of 3.65, 5.87 is 0.13%, 0.04%, 0.04%), and the yield is 89.8%. The content of the impurity of the mycophenolic acid or the mycophenolic acid salt prepared by the invention may be as low as 0.05% or less and less than 0.05%. 'It is far superior to the aforementioned prior art (pri〇r _) of the impurities 201103897 higher than 0.10%. [Simple diagram description] None [Main component symbol description] None

Claims (1)

201103897 七、申請專利範圍: 1. 一種霉盼酸之純化方法,係包括下列步驟: A. 令霉紛酸與醇類進行酯化反應以製得霉酚酸酯或其酸酯衍 生物; B. 令該霉酚酸酯或其酸酯衍生物進行水解反應,以製得高純度 之霉盼酸。 2. 如申請專利範圍第1項之方法,其中令該霉酚酸酯或其酸酯衍 籲 生物進行水解反應係指霉盼酸醋或其酸醋衍生物在驗金屬氫 氧化物水溶液中所進行的水解反應。 3. 如申明專利範圍第2項之方法,其中該鹼金屬氫氧化物係選自 氫氧化鋰、氫氧化鈉與氫氧化鉀之一類者。 4. 一種霉酚酸之純化方法,係當霉酚酸在純化過程中呈現一般有 機>谷劑再結不易去除的深紫色時,係利用有機酸有效地加以移 除。 φ 5.如申5月專利範圍第4項之方法’其中該有機酸係指對-曱苯績 酸。 6. 一種製備高純度霉騎㈣之方法,係令由申請專利範圍第! 項所得之⑧純度#_與含觸有触或無繼進行皂化反 應後,以得到高純度的霉紛酸納鹽。 7. 如申⑺專她圍第6項之方法,其中該高純度的絲酸納鹽, 谢曰霉紛酸納鹽巾所有的個別不純物的含量皆降低至_%或 低於0.05%以下者。 15 201103897201103897 VII. Scope of application: 1. A method for purifying the acid, comprising the following steps: A. esterifying the acid with an alcohol to obtain a mycophenolate ester or an acid ester derivative thereof; The mycophenolate acid ester or its acid ester derivative is subjected to a hydrolysis reaction to obtain a high-purity mycophenolic acid. 2. The method of claim 1, wherein the mycophenolate acid ester or the acid ester thereof is subjected to a hydrolysis reaction, wherein the acid vinegar or the acid vinegar derivative thereof is used in the aqueous metal hydroxide solution. The hydrolysis reaction carried out. 3. The method of claim 2, wherein the alkali metal hydroxide is selected from the group consisting of lithium hydroxide, sodium hydroxide and potassium hydroxide. 4. A method for purifying mycophenolic acid, which is effectively removed by an organic acid when the mycophenolic acid exhibits a deep purple color which is generally difficult to remove during the purification process. φ 5. The method of claim 4 of the May patent scope wherein the organic acid is p-p-phenylene acid. 6. A method for preparing high-purity mold riding (4), which is ordered by the patent application scope! The 8 purity #_ obtained in the item is reacted with a touch or no saponification to obtain a high-purity sodium salt of high acidity. 7. If Shen (7) specializes in her method of item 6, wherein the high-purity sodium salt of silk, the content of all the individual impurities of the Xanthoxylum soda salt is reduced to _% or less than 0.05%. . 15 201103897 四、指定代表圖: (一) 本案指定代表圖為:第( )圖。 (二) 本代表圖之元件符號簡單說明: 無 五、本案若有化學式時,請揭示最能顯示發明特徵的化學式:4. Designation of representative drawings: (1) The representative representative of the case is: ( ). (2) A brief description of the symbol of the representative figure: None 5. If there is a chemical formula in this case, please disclose the chemical formula that best shows the characteristics of the invention: 201103897 【實施方式】 本發明可由以下諸實施例說明其製程,但本發明之範圍並非侷 限在以下所述之實施例。 於下列各實施例中所述及之反應,皆利用高效能液相層析儀 (HPLC,Waters)對反應起始物、中間體以及產物進行分析,高效 能液相層析儀之分析條件如下: 1. 管柱(Column) : ZORBAX,150x4.6 mm,Agilent C8 2. 管柱溫度:45°C 3. 流動相(Mobile phase):混合 350 毫升乙腈(acetonitrile)、650 毫升純水以及2.0毫升三乙胺(triethylamine),以85%填酸水 溶液調混合溶液之pH值至5.3,震盪後使用。 4.流速(Flowrate) : 0.8mL/min. 5. 偵測波長·· 250 nm 6. 注射體積:10uL 於此條件下’經由液相層析儀進行分析所顯示出之不純物, 其吸收峰的相對滯留時間(relative retention times, RRT)之誤差範 圍在-0.05至+0.05之間。 實施例1 (1)合成霉酚酸甲酯(Me%l Mycophenolate) 於反應瓶中加入霉酚酸(9·5克,29.7毫莫耳,其中,不純物 位於 RRT 0.83, 3.65, 6.03 的含量分別為 〇 16〇/〇, 〇 54〇/〇, 〇 54%)與 9 201103897 甲醇(25〇毫升)’室溫下攪拌反應混合物至澄清溶液,加— 甲苯κ酸C(X42克’ 2·4毫莫耳)。加熱反應溶液至迴流,搜掉2 小時。常壓祕出甲醇(150毫升),降溫析晶,液溫達25。(:時以 冰水冷冷部’並於液溫為2。〇時過滤,瓶壁與澄固體以冰甲醇、先 _ 賴體於机錢,得到白色雜產物(9 4克,則亳莫耳),’ 產率94.4%。 (2)霉盼酸曱醋的水解 〇 i溫下’於反應瓶中加入氫氧化納(3.8克,95.0毫莫耳)與 純水(100毫升)’ _混合物至澄清水溶液。加入霉盼酸甲醋(9.〇 克’27.0毫莫耳)’室溫下攪拌21小時。反應溶液以乙酸乙醋(⑽ 毫升)萃取’丟棄有機層。水層以32%鹽酸水溶液調pH值至15, 以乙酸乙醋(100毫升)萃取兩次。合併乙酸乙醋溶液,常壓下蒸 鶴出乙酸乙醋(170亳升),降溫析晶,液溫達洗時以冰水浴冷 卻’並於液溫1c時過遽’槪壁與澄固體以冰乙酸乙醋洗,澄固體 ◎ 於60°C乾燥,得到白色固體產物(7.9克,247毫莫耳,其中,不 純物位於RRT 0.83, 3.65, 6·〇3的含量分別為〇 〇5%,〇 〇3%, 0.02°/。),產率 91.6%。 實施例2 (1)合成霉酚酸甲酯 於反應瓶中加入霉酚酸(3〇.〇克,93 8毫莫耳,其中,不純 物位於 RRT 0.83, 3.65, 5.73 的含量分別為 〇 2〇%,〇 56%,0.42%) 201103897 與甲醇(150毫升),室溫下攪拌反應混合物至澄清溶液,加入對 —甲笨磺酸(1.26克,7.3毫莫耳)。加熱反應溶液至迴流,攪拌2 小時。降溫析晶,室溫下以冰水浴冷卻’並於液溫為2°C時過濾, 瓶壁與溼固體以冰甲醇洗,溼固體於60°C乾燥,得到白色固體產 物(28.8克,86.2毫莫耳),產率95.2%。 (2) 合成霉酚酸2- (4-嗎啉)乙酯 於反應瓶中加入霉酚酸曱酯(20.0克,59.9毫莫耳)、甲苯(74,4 ❹ 克)、2-(4-嗎啉)乙醇(8.3克,63.1毫莫耳)與2-丁基錫氧化物 (1.5克,6.0毫莫耳)’加熱反應混合物至迴流,攪拌1小時。降 溫,於反應溶液内溫46°C時,加入2-丁基錫氧化物(6.0克,24.0 毫莫耳),加熱反應混合物至迴流,於迴流溫度下,擾拌4〇小時。 降溫,於反應溶液内溫48〇C時,加入活性碳(1.0克),攪拌1小 時。加入乙酸乙醋(22.9克),攪拌5分鐘後,經矽藻土(celite) 〖過濾,瓶壁以乙酸乙酯(22.9克)洗,收集、合併濾液與洗液, Q 以純水(45·8克)洗。將有機溶液與純水(45.8克)混合、攪拌, 以32%鹽酸水溶液調pH值至162,靜置分層,丟棄有機層,水層 以乙酸乙醋(45.8克)洗兩次。將水層與二氣甲烧⑷.4克)混 合、攪拌’再以45°/〇氫氧化鈉水溶液調pH值至1〇 83,靜置分層, 收集有機層’水層以二氣甲烧(614克)萃取,合併有機層,以 飽和鈉水溶液洗。將有機層濃縮至乾,⑽殘餘物於6〇c>c 乾燥後’仔到固體產物⑵5克,楊毫莫耳),產率82 8%。 (3) 霉盼酸2- (4-嗎琳)乙酿的水解 201103897 室溫下,於反應瓶中加入氫氧化鈉(3.2克,78.8毫莫耳)與 純水(100毫升)’攪拌混合物至澄清水溶液。加入霉酚酸2- (4-嗎啉)乙酯(10.0克,23.1毫莫耳),室溫下攪拌4小時。反應溶 液以乙酸乙酯(50毫升)萃取兩次,丟棄有機層,將水層與乙酸 乙酯(1〇〇毫升)混合並攪拌,以32%鹽酸水溶液調pH值至136, 靜置分層,收集有機層,水層以乙酸乙酯(5〇毫升)萃取。合併 乙酸乙s旨溶液’常壓下蒸鶴出乙酸乙醋(14G毫升),降溫析晶, 〇 液溫達乃乞時以冰水浴冷卻,並於液溫為2°c時過濾,瓶壁與溼 固體以冰乙酸乙酯洗’溼固體於60〇c乾燥,得到白色固體產物(69 克’ 21.6毫莫耳’其中,不純物位於RRT 0.83, 3.65, 5.73的含量 分別為 0.03%,<0.01%,0.01%),產率 % 5%。 實施例3霉酚酸除色 I 將紫色的霉紛酸(30.0克,93.8毫莫耳)與丙酮(15〇毫升) 1 於反應瓶中混合、授拌,加入對—曱笨績酸(〇 62克,3 6毫莫耳)。 ❹加熱混合物至迴流(紫色消失,溶液呈淡黃色)。降溫析晶,室溫 下以冰水浴冷卻,並於液溫為2ΐ時過濾,紐與麵體以冰丙網 洗,座固體於60 C乾燥’得到白色霉紛酸(24克,75亳莫耳), 產率80%。 實施例4霉酚酸鈉鹽的製備 於反應瓶t加人霉崎(5克,15 63毫莫耳,其中,不純物 201103897 位於RRT 0.83, 3·65的含量分別為〇·〇5%,〇 〇1%)、氮氧化納(〇仍 克’ 15.63毫莫耳)以及甲醇⑽毫升),加熱反應混合物至迴流, 攪拌〇.5小時後’蒸德出甲醇(7〇毫升)。降溫,於液溫為耽時 加入異丙醇(70毫升),加熱混合物至迴流並蒸德出甲醇/異丙 軌合液⑺毫升)。降溫’於液溫為2(C時過遽,瓶壁與溼固 豸以異瞒洗’觀辦贼賴’得卿體產㈣盼酸納鹽 (5.12克,14.97毫莫耳,其中,不純物位於65的含 0 量分別為 0.04%,<0.01%),產率 95.8%。 實施例5霉酚酸鈉鹽的製備(比較製程) 於反應瓶中加入霉酚酸(5克,15 63毫莫耳,其中,不純物 位於 RRT 0.83, 3.65, 5.87 的含量分別為 〇.17%,〇 56%, 〇 48%)、氮 氧化鈉(0.625克’ 15.63毫莫耳)以及甲醇(励毫升),加熱反 應混合物至迴流,攪拌〇.5小時後,蒸餾出甲醇(7〇毫升)。降溫, ❹於液溫&机時加入異啤(70 $升),加熱混合物至迴流,並 蒸館出甲醇/異丙醇混合液(7〇毫升)。降溫,於液溫為坑時過 濾,瓶壁與溼固體以異丙醇洗,溼固體於6〇。〇乾燥,得到固體產 物霉酚酸鈉鹽(4.8克,14.04毫莫耳,其中,不純物位於rrt0.83, 3.65, 5.87 的含量分別為 〇13%,〇 〇4%,〇 〇4%),產率 89 8%。 本發明製得之霉酚酸或霉酚酸鈉鹽其不純物含量可低至 0.05°/❶或低於0.05%以下’遠優於前述先前技術(pri〇rarts)之不純物[Embodiment] The present invention can be illustrated by the following embodiments, but the scope of the present invention is not limited to the embodiments described below. In the reactions described in the following examples, the reaction starting materials, intermediates and products were analyzed by high performance liquid chromatography (HPLC, Waters). The analytical conditions of the high performance liquid chromatography were as follows. : 1. Column: ZORBAX, 150x4.6 mm, Agilent C8 2. Column temperature: 45 °C 3. Mobile phase: Mix 350 ml of acetonitrile, 650 ml of pure water and 2.0 Triethylamine (triethylamine), the pH of the mixed solution was adjusted to 5.3 with 85% aqueous acid solution, and used after shaking. 4. Flowrate: 0.8mL/min. 5. Detection wavelength · · 250 nm 6. Injection volume: 10uL Under these conditions, the impurities displayed by liquid chromatography are analyzed for their absorption peaks. The relative retention times (RTT) have an error ranging from -0.05 to +0.05. Example 1 (1) Synthesis of methyl mycophenolate (Me%l Mycophenolate) Mycophenolic acid (9·5 g, 29.7 mmol) was added to the reaction flask, wherein the impurities were at RRT 0.83, 3.65, 6.03, respectively. 〇16〇/〇, 〇54〇/〇, 〇54%) and 9 201103897 methanol (25〇ml)' Stir the reaction mixture to a clear solution at room temperature, add -toluene κ C (X42 g ' 2·4 Millions of ears). The reaction solution was heated to reflux and searched for 2 hours. Atmospheric pressure of methanol (150 ml), cooling and crystallization, liquid temperature up to 25. (: When the cold water is cold and cold, and the liquid temperature is 2. When filtering, the bottle wall and the solid solid are iced methanol, first _ Lai body to the machine money, to get white miscellaneous products (9 4 grams, then Momo ), 'yield 94.4%. (2) hydrolysis of myristic acid vinegar 〇i temperature' Add sodium hydroxide (3.8 g, 95.0 mmol) to pure water (100 ml) in the reaction flask. To clear the aqueous solution. Add the myristic acid methyl vinegar (9. gram '27.0 mmol) to stir at room temperature for 21 hours. The reaction solution was extracted with ethyl acetate (10 ml) to discard the organic layer. The water layer was 32%. The aqueous solution of hydrochloric acid was adjusted to pH 15 and extracted twice with ethyl acetate (100 ml). The ethyl acetate solution was combined, and the acetic acid was evaporated under reflux (170 liters) to reduce the temperature and crystallize. The mixture was cooled in an ice water bath and washed at a liquid temperature of 1 c. The mixture was washed with glacial acetic acid, and dried at 60 ° C to give a white solid product (7.9 g, 247 mmol). The impurities were located at RRT 0.83, 3.65, and 6.·3 were 〇〇5%, 〇〇3%, 0.02°/.), and the yield was 91.6%. Example 2 (1) Synthetic methyl mycophenolate was added to the reaction flask to add mycophenolic acid (3 〇. gram, 93 8 mmol), wherein the impurities were located at RRT 0.83, 3.65, 5.73, respectively. %, 〇56%, 0.42%) 201103897 With methanol (150 ml), the reaction mixture was stirred at room temperature to a clear solution, and p-methylsulfonic acid (1.26 g, 7.3 mmol) was added. The reaction solution was heated to reflux. Stir for 2 hours, cool down and crystallize, cool in an ice water bath at room temperature and filter at a liquid temperature of 2 ° C. The bottle wall and wet solid are washed with ice methanol, and the wet solid is dried at 60 ° C to obtain a white solid product ( 28.8 g, 86.2 mmol, yield 95.2%. (2) Synthetic mycophenolate 2-(4-morpholine)ethyl ester was added to the reaction flask with decyl phenolate (20.0 g, 59.9 mmol) Toluene (74,4 gram), 2-(4-morpholine)ethanol (8.3 g, 63.1 mmol) and 2-butyltin oxide (1.5 g, 6.0 mmol) were heated to reflux. Stir for 1 hour. Cool down, add 2-butyltin oxide (6.0 g, 24.0 mmol) to the reaction solution at an internal temperature of 46 ° C. The mixture was refluxed at reflux temperature for 4 hours. When the temperature was lowered at 48 ° C, the activated carbon (1.0 g) was added and stirred for 1 hour. Ethyl acetate (22.9 g) was added and stirred. After a minute, celite was filtered, the wall of the bottle was washed with ethyl acetate (22.9 g), and the filtrate and washing solution were collected and mixed, and Q was washed with pure water (45·8 g). Water (45.8 g) was mixed and stirred, and the pH was adjusted to 162 with a 32% aqueous hydrochloric acid solution, and the mixture was allowed to stand, and the organic layer was discarded, and the aqueous layer was washed twice with ethyl acetate (45.8 g). Mix the water layer with the two gas (4).4g), stir and adjust the pH to 1〇83 with 45°/〇 sodium hydroxide solution, let stand for layering, collect the organic layer 'water layer to two gas The mixture was fired (614 g), and the combined organic layers were washed with saturated aqueous sodium. The organic layer was concentrated to dryness. (10) The residue was dried at <RTI ID=0.0>>>>> (3) Hydrolysis of 2- (4-Merline) B. 201103897 Stirring mixture of sodium hydroxide (3.2 g, 78.8 mmol) and pure water (100 ml) was added to the reaction flask at room temperature. To clear the aqueous solution. 2- (4-morpholine)ethyl mycophenolate (10.0 g, 23.1 mmol) was added and stirred at room temperature for 4 hours. The reaction solution was extracted twice with ethyl acetate (50 mL). The organic layer was evaporated, and the aqueous layer was mixed with ethyl acetate (1 ml) and stirred, and adjusted to pH 136 with a 32% aqueous hydrochloric acid solution. The organic layer was collected and the aqueous layer was extracted ethyl acetate (5 mL). Combined with acetic acid ethyl s solution, steamed crane to ethyl acetate (14G ml) under normal pressure, and cooled and crystallized. When the temperature of the mash is reached, it is cooled in an ice water bath and filtered at a liquid temperature of 2 ° C. Drying with wet solids in EtOAc (br.) washed with EtOAc EtOAc (EtOAc: EtOAc: EtOAc: EtOAc: EtOAc 0.01%, 0.01%), yield % 5%. Example 3 Mycophenolic Acid Decolorization I Mix purple mycophenolic acid (30.0 g, 93.8 mmol) with acetone (15 ml) 1 in a reaction flask, mix and mix, and add p-benzoic acid (〇 62 grams, 3 6 millimoles). The mixture was heated to reflux (purple disappeared and the solution was pale yellow). Cooling and crystallization, cooling in an ice water bath at room temperature, and filtering at a liquid temperature of 2 ,, the nucleus and the surface body are washed with ice-acrylic mesh, and the solid is dried at 60 C to obtain white moldy acid (24 g, 75 亳 mo Ear), yield 80%. Example 4 Preparation of Mycophenolate Sodium Salt In the reaction bottle, t was added to the mold (5 g, 15 63 mmol, wherein the impurity 201103897 was located at RRT 0.83, and the content of 3.65 was 〇·〇 5%, respectively. 〇1%), sodium oxynitride (〇 gram ' 15.63 mmol) and methanol (10 ml), the reaction mixture was heated to reflux, stirred for 5 hours, and then evaporated to methanol (7 mL). The temperature was lowered. When the liquid temperature was 耽, isopropanol (70 ml) was added, and the mixture was heated to reflux and evaporated to give a methanol/isopropyl chloride solution (7 ml). Cooling 'in liquid temperature is 2 (C when the sputum, bottle wall and wet solid 豸 瞒 ' ' 观 观 观 观 观 观 ' 得 得 得 得 得 得 得 得 得 得 得 得 得 盼 盼 盼 盼 盼 盼 盼 盼 盼 盼 盼 盼 5.1 5.1 5.1 5.1 5.1 5.1 5.1 5.1 5.1 5.1 5.1 5.1 The amount of 0 at 65 was 0.04%, <0.01%, respectively, and the yield was 95.8%. Example 5 Preparation of Mycophenolate Sodium Salt (Comparative Process) Mycophenolic acid (5 g, 15 63) was added to the reaction flask. Milliohms, wherein the impurities are located at RRT 0.83, 3.65, 5.87, respectively, 〇.17%, 〇56%, 〇48%), sodium oxynitride (0.625 g '15.63 mmol), and methanol (ML) Heat the reaction mixture to reflux, stir for 5 hours, distill off methanol (7 mL). Cool down, add the beer (70 $L) to the liquid temperature & machine, heat the mixture to reflux, and steam. Methanol / isopropanol mixture (7 〇 ml). Cool down, filter when the liquid temperature is pit, wash the bottle wall and wet solid with isopropyl alcohol, wet solid at 6 〇. Dry to obtain solid product mycophenolic acid Sodium salt (4.8 g, 14.04 mmol), wherein the impurities are located at rrt 0.83, 3.65, 5.87, respectively, 〇13%, 〇〇4%, 〇 〇4%), yield 89 8%. The mycophenolic acid or mycophenolate sodium salt prepared by the invention may have an impurity content as low as 0.05 ° / ❶ or less than 0.05% 'far better than the aforementioned prior art (pri 〇rarts)
TW98124527A 2009-07-21 2009-07-21 Purification method of mycophenolic acid and method for preparing high purity sodium mycophenolate using the same TW201103897A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW98124527A TW201103897A (en) 2009-07-21 2009-07-21 Purification method of mycophenolic acid and method for preparing high purity sodium mycophenolate using the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW98124527A TW201103897A (en) 2009-07-21 2009-07-21 Purification method of mycophenolic acid and method for preparing high purity sodium mycophenolate using the same

Publications (2)

Publication Number Publication Date
TW201103897A true TW201103897A (en) 2011-02-01
TWI382023B TWI382023B (en) 2013-01-11

Family

ID=44813368

Family Applications (1)

Application Number Title Priority Date Filing Date
TW98124527A TW201103897A (en) 2009-07-21 2009-07-21 Purification method of mycophenolic acid and method for preparing high purity sodium mycophenolate using the same

Country Status (1)

Country Link
TW (1) TW201103897A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106905274A (en) * 2017-03-04 2017-06-30 丽珠集团新北江制药股份有限公司 A kind of recovery method of MMF mother liquor
CN108727318A (en) * 2017-04-25 2018-11-02 鲁南制药集团股份有限公司 The crystal form object of Mycophenolic Acid
CN116120266A (en) * 2021-11-12 2023-05-16 重庆圣华曦药业股份有限公司 A kind of preparation method of mycophenolate sodium
CN117417317A (en) * 2023-10-17 2024-01-19 北大医药重庆大新药业股份有限公司 A kind of preparation method of mycophenolate sodium

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200613294A (en) * 2004-04-26 2006-05-01 Teva Gyogyszergyar Reszvenytarsasag Process for preparation of mycophenolic acid and ester derivatives thereof

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106905274A (en) * 2017-03-04 2017-06-30 丽珠集团新北江制药股份有限公司 A kind of recovery method of MMF mother liquor
CN108727318A (en) * 2017-04-25 2018-11-02 鲁南制药集团股份有限公司 The crystal form object of Mycophenolic Acid
CN116120266A (en) * 2021-11-12 2023-05-16 重庆圣华曦药业股份有限公司 A kind of preparation method of mycophenolate sodium
CN117417317A (en) * 2023-10-17 2024-01-19 北大医药重庆大新药业股份有限公司 A kind of preparation method of mycophenolate sodium

Also Published As

Publication number Publication date
TWI382023B (en) 2013-01-11

Similar Documents

Publication Publication Date Title
CN111875538B (en) Synthetic method of pitavastatin tert-butyl ester
JP4358295B2 (en) Process for producing benzoxazine derivative and its intermediate
CN110698461B (en) Preparation method of third-generation EGFR inhibitor
JP5575921B2 (en) Method for producing tetrazole methanesulfonate and novel compound used therefor
TW201103897A (en) Purification method of mycophenolic acid and method for preparing high purity sodium mycophenolate using the same
CN108623456A (en) The preparation method of butylphenyl phthaleine and its pharmaceutical intermediate
WO2016055015A1 (en) Method for preparing sitagliptin intermediate via asymmetrical reduction method
CN102643194B (en) Preparation method of posaconazole intermediate
CN104829590B (en) Method for purifying trelagliptin
CN105524042B (en) A method of preparing bent Ge Lieting
CN107056681B (en) A kind of support method replaces the preparation method of cloth intermediate
WO2011147279A1 (en) Preparation method of 5-[[2(r)-[1(r)-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3(s)-4-fluorophenyl-4-morpholinyl]methyl]-1,2-dihydro-3h-1,2,4-triazole-3-one
JP4783998B2 (en) Preparation of (3R, 5S) -7-substituted-3,5-dihydroxyhept-6-enoic acid
WO1998047873A1 (en) Process for producing quinolone derivatives
CN114890999B (en) A kind of preparation method of PQQ
TW202019872A (en) Preparation method for fused tricyclic [gamma]-amino acid derivative and intermediate thereof
JPWO2014051077A1 (en) Method for producing high purity nitrogen-containing heterocyclic compound
CN104031034B (en) A kind of preparation method of pitavastatin calcium raw material drug intermediate
CN106278928A (en) A kind of synthetic method of oseltamivir phosphate isomer impurities
CN103288813A (en) Preparation method of aprepitant
WO2015012271A1 (en) Method for producing heterocyclic compound
CN104892491A (en) Method for synthesizing paroxetine chiral intermediate
JP4258104B2 (en) trans-dicyclohexyl-3,3'4,4'-tetracarboxylic acid tetramethyl and tetraethyl
CN106632340A (en) A kind of method of synthesizing tenofovir intermediate
CN119306645A (en) Method for preparing pyrrolamide compound and intermediate thereof

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees